Is CytoMed Therapeutics Limited (GDTC) a Buy, Sell, or Hold?
NASDAQ : GDTC
CytoMed Therapeutics Limited — Insider Trades
$0.91 USD
$0.0 (0.54%)
- Volume
- 17.54K
- Average Volume
- 70.28K
- Market Capitalization
- $10.77M
- P/E Ratio
- -2.90
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.68
- Year Low
- $0.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.17
Insider Activity Summary (Last 12 Months)
Insiders Buying
0
Insiders Selling
0
Amount of Insider Selling
-$
GDTC Insider Buying/Selling by Quarter
GDTC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Choo Chee Kong | director, 10 percent owner: | 2026-07-20 | P-Purchase | 1.5 | 2026-07-24 |
| Choo Chee Kong | director, 10 percent owner: | 2026-07-14 | P-Purchase | 1.5 | 2026-07-24 |
| Choo Chee Kong | director, 10 percent owner: | 2026-07-20 | P-Purchase | 1.5 | 2026-07-24 |
| Choo Chee Kong | director, 10 percent owner: | 2026-07-14 | P-Purchase | 1.5 | 2026-07-24 |
| Choo Chee Kong | director, 10 percent owner: | 2026-05-13 | P-Purchase | 1.1498 | 2026-06-15 |
| Toh Keng Kiat | director | 2026-03-18 | 0 | 2026-05-26 | |
| Yew Chak Hua | director | 2026-03-18 | 0 | 2026-05-15 | |
| Leong Mark Kei Wei | director: | 2026-03-18 | 0 | 2026-05-15 | |
| Choo Chee Kong | director, 10 percent owner: | 2026-03-18 | 0 | 2026-05-15 | |
| Choo Chee Kong | director, 10 percent owner: | 2026-03-18 | 0 | 2026-05-15 | |
| Choo Chee Kong | director, 10 percent owner: | 2026-03-18 | 0 | 2026-05-15 | |
| TAN YOONG YING | officer: Chief Corporate Officer | 2026-03-18 | 0 | 2026-05-15 | |
| Goh Yvonne | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-05-15 |